CITIZENS FINANCIAL GROUP INC/RI
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 759944
PROVIDENCE, RI
Position in REGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$3,689,356
+$710,710 QoQ
Shares Held
4,775
+23.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIZENS FINANCIAL GROUP INC/RI holds $30,686,913 across 14 Biotechnology names. REGN ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,824 | $22,248,408 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,775 | $3,689,356 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
25,822 | $1,668,875 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
261,890 | $913,996 | |
| 5 | IMNM |
Immunome Inc.
|
19,954 | $436,393 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,082 | $303,129 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
4,963 | $288,598 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,605 | $283,288 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,689,356 | 4,775 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $2,978,646 | 3,859 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $2,034,292 | 3,618 | Shares | Defined | 2025-10-24 | |
| 2025-06-30 | $1,395,975 | 2,659 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $499,773 | 788 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $892,549 | 1,253 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $12,633,801 | 12,018 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $12,748,993 | 12,130 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $11,552,766 | 12,003 | Shares | Defined | 2024-05-17 | |
| 2023-12-31 | $10,786,279 | 12,281 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $10,127,344 | 12,306 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,125,457 | 12,700 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $10,373,583 | 12,625 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $9,344,737 | 12,952 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $9,479,539 | 13,761 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $8,135,130 | 13,762 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $9,739,466 | 13,945 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $8,920,851 | 14,126 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $8,700,672 | 14,377 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $8,218,915 | 14,715 | Shares | Defined | 2021-08-04 | |
| 2020-06-30 | $39,289 | 63 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $13,183 | 27 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||